$BAP

Credicorp Q2 Earnings Call Highlights

Credicorp (NYSE:BAP) discussed Q2 results and outlook on an earnings call, including plans to reassess El Niño-related expected losses by late Q3 or early Q4. Management said full-year 2026 cost of risk should stay within guidance, raised 2026 loan-growth to ~12% and fee-income to high-teens, and reaffirmed 2026 ROE guidance ~19.5%. BCP ROE 29.2%, Mibanco ROE 22.9%, Yape has 16M+ MAUs.

Original reporting
Published Aug 14, 2026, 4:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 14, 2026, 4:56 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Credicorp Q2 Earnings Call Highlights — source image
Decision brief

The 30-second read

$BAPBullishMed
01

Why it matters

Traders can update 2026 expectations using the raised loan-growth and fee-income outlook, while monitoring the planned reassessment of El Niño losses around late Q3 or early Q4.

02

Market read

Updated 2026 guidance and quantified segment metrics provide a fresh basis for repricing BAP’s growth, fee, and risk-cost outlook, with El Niño as the key swing factor.

03

What to watch

Yape and other disruptive expenses rose sharply (noted as 84% of disruptive expenses), which could pressure efficiency if growth slows or credit costs re-accelerate.

Relevance 8/10Novelty 7/10Timing: during/after the Q2 earnings call, with 2026 outlook updates

Background

Credicorp’s Q2 call highlights portfolio performance across BCP, Mibanco, and digital platform Yape, alongside risk management plans for El Niño-related expected losses.

Company-level read

Ticker impact

$BAPBullishMedium confidence
Context

Credicorp raised 2026 loan-growth outlook to ~12% and fee-income to high-teens, while reaffirming ROE ~19.5% with El Niño-dependent bias.

Expected impact

Moderately positive bias for BAP as traders weigh higher growth and fee outlook against El Niño cost-of-risk variability.

Evidence & confidence

The article provides specific updated outlook ranges (loan growth, fee growth, NIM and efficiency expectations) plus quantified segment metrics and a stated plan to reassess El Niño losses later in the year.

Market effects

Peru financials may see read-across on credit-cost normalization and digital lending momentum, but El Niño risk remains a common macro overhang.

Could influence sentiment toward Peru banking and microfinance peers via guidance and cost-of-risk commentary tied to El Niño severity.

Limited direct global spillover, but it reinforces how emerging-market banks are managing climate-linked credit risk and provisioning.

Counterpoint

The guidance bias to the upside is explicitly contingent on El Niño development, so upside may be fragile if severity worsens and provisions rise.

Key entities

  • Credicorp Ltd.

    Peru-based financial holding company with banking, microfinance, insurance, and investment management operations.

  • Banco de Crédito del Perú (BCP)

    Major banking unit whose retail momentum and cost-of-risk normalization are cited in the outlook update.

  • Mibanco

    Microfinance unit reporting record-low NPL ratio and contributing to the raised growth outlook.

  • Yape

    Credicorp’s payments and lending platform with 16M+ monthly active users and rapidly growing loan balances.

  • Cesar Rios

    Chief Risk Officer who described surgical risk appetite adjustments in more vulnerable portfolio areas.

Related articles

$BAPHighAI 9/10

Bapcor Shares Upgraded, As Price Target Slashed: Value or Trap?

Jefferies upgraded Bapcor (ASX: BAP) to Buy from Hold but cut its price target from A$1.05 to A$0.65. The stock has fallen about 75% over six months and is near A$0.38. Bapcor also secured temporary relief on its net leverage covenant, raising it to 3.5x adjusted EBITDA for test dates through 2026.

$CRTDLow

Creatd, Inc. (CRTD): Results of Operations and Financial Condition

Creatd, Inc. (CRTD) filed an SEC Form 8-K — Results of Operations and Financial Condition. crtd-20260814 0001357671 false 0001357671 2026-08-14 2026-08-14 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________________________ FORM 8-K ___________________________________ CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securitie

$TGMed

Tredegar Soars on Q2 Financials

Tredegar Corp (NYSE:TG) reported Q2 2026 results for the period ended June 30, 2026. Net income from continuing operations rose to $6.0 million, or $0.17 per diluted share, from $1.8 million, or $0.05 per share, in Q2 2025. Excluding special items, net income was $6.4 million, or $0.18 per share. Aluminum Extrusions EBITDA was $14.5 million versus $9.3 million in Q2 2025.

$ANYMed

Sphere 3D Corp. (ANY): Results of Operations and Financial Condition

Sphere 3D Corp. (ANY) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 exhibit99-1.htm EXHIBIT 99.1 Sphere 3D Corp.: Exhibit 99.1 - Filed by newsfilecorp.com Exhibit 99.1 Sphere 3D Provides Business Update and Reports Second Quarter 2026 Financial Results Combined Company Positioned for Its Next Phase of Growth Through Power-Ready Infrastr